MicroRNA profiling of Chinese primary glioblastoma reveals a temozolomide-chemoresistant subtype

Accumulating evidence demonstrates that defining molecular subtypes based on objective genetic alterations may permit a more rational, patient-specific approach to molecular targeted therapy across various cancers. The objective of this study was to subtype primary glioblastoma (pGBM) based on Micro...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Wei, Liu, Yanwei, Yang, Pei, Wang, Zheng, You, Yongping, Jiang, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484485/
https://www.ncbi.nlm.nih.gov/pubmed/25869098

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484485/
https://www.ncbi.nlm.nih.gov/pubmed/25869098

Ejemplares similares